Statistical issues in drug development
保存先:
| 第一著者: | |
|---|---|
| 団体著者: | |
| フォーマット: | 電子媒体 eBook |
| 言語: | 英語 |
| 出版事項: |
Chichester, England ; Hoboken, NJ :
John Wiley & Sons,
c2007.
|
| 版: | 2nd ed. |
| シリーズ: | Statistics in practice.
|
| 主題: | |
| オンライン･アクセス: | An electronic book accessible through the World Wide Web; click to view |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
目次:
- A brief and superficial history of statistics for drug developers
- Design and interpretation of clinical trials as seen by a statistician
- Probability, Bayes, P-values, tests of hypotheses, and confidence intervals
- The work of the pharmaceutical statistician
- Allocating treatments to patients in clinical trials
- Baselines and covariate information
- The measurement of treatment effects
- Demographic subgroups : representation and analysis
- Multiplicity
- Intention to treat, missing data and related matters
- One-sided and two-sided tests and other issues to do with significance and P-values
- Determining the sample size
- Multicentre trials
- Active control equivalence studies
- Meta-analysis
- Cross-over trials
- n-of-1 trials
- Sequential trials
- Dose-finding
- Concerning pharmacokinetics and pharmacodynamics
- Bioequivalence studies
- Safety data, harms, drug monitoring, and pharmaco-epidemiology
- Pharmaco-economics and portfolio management
- Concerning pharmacogenetics, pharmacogenomics, and related matters.